Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rosuvastatin Augments Dipyridamole Induced Vasodilation by Increased Adenosine Receptor Stimulation.

NCT00554138 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT00554138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00554138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rosuvastatin Augments Dipyridamole Induced Vasodilation by Increased Adenosine Receptor Stimulation.
Lead sponsor
Radboud University Medical Center
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2007
Completion date
April 30, 2008
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenosine metabolism